An investigation into solvent-membrane interactions when assessing drug release from organic vehicles using regenerated cellulose membranes

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 9, 2008, Pages 1139-1147

  Reid, Monica L ^a   Brown, Marc B ^b   Moss, Gary P ^b   Jones, Stuart A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BECLOMETASONE DIPROPIONATE MONOHYDRATE; BETAMETHASONE VALERATE; CELLULOSE; CORTICOSTEROID; DEXTRAN; ORGANIC SOLVENT;

ARTICLE; ARTIFICIAL MEMBRANE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY;

BECLOMETHASONE; BETAMETHASONE 17-VALERATE; CELLULOSE; DIFFUSION; GLUCOCORTICOIDS; MEMBRANES, ARTIFICIAL; SOLUBILITY; SOLVENTS; VEHICLES;

EID: 49749088901     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.9.0004     Document Type: Article

References (47)

1. Abram, A. Z. Mousse Composition. 09/719,662[6,730,288]. 2004. US. Ref Type: Patent
2. Babar, A., Ray, S. D., Patel, N. K., Plakogiannis, F. M., Gogineni, P. (1999) In vitro release and diffusion studies of promethazine hydrochloride from polymeric dermatological bases using cellulose membrane and hairless mouse skin. Drug Dev. Ind. Pharm. 25: 235-240
3. Bendas, B., Schmalfuss, U., Neubert, R. (1995) Influence of propylene-glycol as cosolvent on mechanisms of drug transport from hydrogels. Int. J. Pharm. 116: 19-30
4. Bowen, J. L., Heard, C. M. (2006) Film drying and complexation effects in the simultaneous skin permeation of ketoprofen and propylene glycol from simple gel formulations. Int. J. Pharm. 307: 251-257
5. Bronaugh, R. L., Stewart, R. F. (1984) Methods for invitro percutaneous-absorption studies. 3. Hydrophobic compounds. J. Pharm. Sci. 73: 1255-1258
6. Coldman, M. F., Poulsen, B. J., Higuchi, T. (1969) Enhancement of percutaneous absorption by use of volatile-nonvolatile systems as vehicles. J. Pharm. Sci. 58: 1098-1102
7. Craig, L. C., Konigsberg, W. (1961) Dialysis studies. 3. Modification of pore size and shape in cellophane membranes. J. Phys. Chem. 65: 166-172
8. Crison, J. R., Shah, V. P., Skelly, J. P., Amidon, G. L. (1996) Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine. J. Pharm. Sci. 85: 1005-1011
9. Davis, A. F., Hadgraft, J. (1991) Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate. Int. J. Pharm. 76: 1-8
10. Dias, C. R., Rosa, M. J., de Pinho, M. N. (1998) Structure of water in asymmetric cellulose ester membranes: an ATR-FTIR study. J. Membrane Sci. 138: 259-267
11. Dias, M., Farinha, A., Faustino, E., Hadgraft, J., Pais, J., Toscano, C. (1999) Topical delivery of caffeine from some commercial formulations. Int. J. Pharm. 182: 41-47
12. Dias, M., Raghavan, S. L., Hadgraft, J. (2001) ATR-FTIR spectroscopic investigations on the effect of solvents on the permeation of benzoic acid and salicylic acid through silicone membranes. Int. J. Pharm. 216: 51-59
13. Dias, M., Hadgraft, J., Lane, M. E. (2007) Influence of membrane-solvent-solute interactions on solute permeation in model membranes. Int. J. Pharm. 336: 108-114
14. Dudley, R. E., Kottayil, S. G., Palatchi, O. (2003) Pharmaceutical composition and method for treating hypogonadism. [6,503,894]. 2003. Ref Type: Patent
15. Fedors, R. F. (1974) Method for estimating both solubility parameters and molar volumes of liquids. Polymer Eng. Sci. 14: 147-154
16. Fink, H.-P., Weigel, P., Purz, H. J., Ganster, J. (2001) Structure formation of regenerated cellulose materials from NMMO-solutions. Prog. Polymer Sci. 26: 1473-1524
17. Gelotte, K. M., Lostritto, R. T. (1990) Solvent interaction with polydimethylsiloxane membranes and its effects on benzocaine solubility and diffusion. Pharm. Res. 7: 523-529
18. Grainger, C. I., Greenwell, L. L., Lockley, D. J., Martin, G. P., Forbes, B. (2006) Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm. Res. 23: 1482-1490
19. Haigh, J. M., Smith, E. W. (1994) The selection and use of natural and synthetic membranes for in-vitro diffusion experiments. Eur. J. Pharm. Sci. 2: 311-330
20. Higuchi, T. (1960) Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmetic Chem. 11: 85-97
21. Houk, J., Guy, R. H. (1988) Membrane models for skin penetration studies. Chem. Rev. 88: 455-471
22. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (1996) Q2(R1): validation of analytical procedures: text and methodology
23. Iordanskii, A. L., Feldstein, M. M., Markin, V. S., Hadgraft, J., Plate, N. A. (2000) Modeling of the drug delivery from a hydrophilic transdermal therapeutic system across polymer membrane. Eur. J. Pharm. Biopharm. 49: 287-293
24. Keyhanimorrison, E., Nadkarni, S., Sakr, A. (1995) Optimization of an in-vitro method for evaluating the release of a novel retinoid from topical gels. Pharm. Ind. 57: 414-419
25. Lindau, J., Jonsson, A. S., Wimmerstedt, R. (1995) The influence of a low-molecular hydrophobic solute on the flux of polysulphone ultrafiltration membranes with different cut-off. J. Membrane Sci. 106: 9-16
26. Maddock, W. G., Coller, F. A. (1933) The role of the extremities in the dissipation of heat. Am. J. Physiol. 106: 589-596
27. Medicell International Ltd (2007) Chemical tolerances of regenerated cellulose membrane http://www.visking.com/Visk_Tech_ChemTol.htm.
28. Megrab, N. A., Williams, A. C., Barry, B. W. (1995) Estradiol permeation through human skin and silastic membrane-effects of propyleneglycol and supersaturation. J. Control. Release 36: 277-294
29. Moser, K., Kriwet, K., Froehlich, C., Naik, A., Kalia, Y. N., Guy, R. H. (2001) Permeation enhancement of a highly lipophilic drug using supersaturated systems. J. Pharm. Sci. 90: 607-616
30. Murphy, D., de Pinho, M. N. (1995) An ATR-FTIR study of water in cellulose acetate membranes prepared by phase inversion. J. Membrane Sci. 106: 245-257
31. OECD (2004) Skin absorption: in vivo method, No. 428. OECD Guideline for the Testing of Chemicals
32. Pellett, M. A., Davis, A. F., Hadgraft, J. (1994) Effect of supersaturation on membrane transport: 2. Piroxicam. Int. J. Pharm. 111: 1-6
33. Pellett, M. A., Castellano, S., Hadgraft, J., Davis, A. F. (1997a) The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J. Control. Release 46: 205-214
34. Pellett, M. A., Watkinson, A. C., Hadgraft, J., Brain, K. R. (1997b) Comparison of permeability data from traditional diffusion cells and ATR-FTIR spectroscopy. 1. Synthetic membranes. Int. J. Pharm. 154:205-215
35. Pellett, M. A., Watkinson, A. C., Hadgraft, J., Brain, K. R. (1997c) Comparison of permeability data from traditional diffusion cells and ATR-FTIR spectroscopy. 2. Determination of diffusional pathlengths in synthetic membranes and human stratum corneum. Int. J. Pharm. 154:217-227
36. Reed, B. L., Morgan, T. M., Finnin, B. C. (2004) Dermal penetration enhancers and drug delivery systems involving the same. [6818226]. 2004. Ref Type: Patent
37. Schwarb, F. P., Imanidis, G., Smith, E. W., Haigh, J. M., Surber, C. (1999) Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin. Pharm. Res. 16: 909-915
38. Shah, V. P., Konecny, J. J., Everett, R. L., Mccullough, B., Noorizadeh, A. C., Skelly, J. P. (1989) Invitro dissolution profile of water-insoluble drug-dosage forms in the presence of surfactants. Pharm. Res. 6:612-618
39. Shah, V. P., Elkins, J., Skelly, J. P. (1992) Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams. J. Pharm. Sci. 81: 104-106
40. Shin, S. C., Lee, H. J. (2002) Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems. Eur. J. Pharm. Biopharm. 54: 201-206
41. Sloan, K. B., Koch, S. A. M., Siver, K. G., Flowers, F. P. (1986) Use of solubility parameters of drug and vehicle to predict flux through skin. J. Invest. Dermatol. 87: 244-252
42. Suhonen, T. M., Bouwstra, J. A., Urtti, A. (1999) Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J. Control. Release 59: 149-161
43. Tuwiner, S. (1962) Cellulose membranes. Diffusion and membrane technology. Reinhold Publishing Corporation, New York, pp 180-199
44. Twist, J. N., Zatz, J. L. (1988) Membrane solvent solute interaction in a model permeation system. J. Pharm. Sci. 77: 536-540
45. Twist, J. N., Zatz, J. L. (1990) A model for alcohol-enhanced permeation through polydimethylsiloxane membranes. J. Pharm. Sci. 79:28-31
46. US Dept of Heath and Human Services, FDA, CDER (1997) Scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro release testing and in vivo bioequivalence documentation. Guidance for Industry
47. Watkinson, A. C., Joubin, H., Green, D. M., Brain, K. R., Hadgraft, J. (1995) The influence of vehicle on permeation from saturated solutions. Int. J. Pharm. 121: 27-36